FDA Inspection 1050487 — Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd.
The FDA completed an inspection of Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. on March 23, 2018 in Nanjing. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 23, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nanjing (China)